Research Brief
Glutathione: Mechanism of Action
20 Citacoes PubMedRevisado por EspecialistasCertificado GMPUltima Revisao: julho de 2026
Mecanismo de Acao
Glutathione (GSH) nao function atraves de um(a) single classical receptor-ligand interaction. Instead, it acts como um(a) pervasive biochemical modulator of cellular redox state, enzymatic cofactor, and signaling regulator via post-traducaoal protein modification.[3]
Primary Biochemical Targets & Binding Characteristics
| Target / Mechanism | Detail | Evidence |
|---|---|---|
| S-Glutathionylation | Reversible post-traducaoal modification; GSH forms mixed disulfide bonds with reactive cysteine residues on target proteins (protein-SSG), acting como um(a) redox "on/off" switch for regulatory, structural, and metabolic proteins | Ballatori et al. (2009)[3] |
| Glutathione Peroxidases (GPx) | GSH serves como o(a) essencial electron donor for GPx-catalyzed reduction of H2O2 and lipid hydroperoxides to water/alcohols, oxidizing GSH to GSSG | Ballatori et al. (2009)[3] |
| Glutathione S-Transferases (GSTs) | GSH conjugates with electrophilic xenobiotics, heavy metals (Hg, Pb), and endogenous toxins (Phase II detoxification), rendering them water-soluble for excrecao | Ballatori et al. (2009)[3] |
| Metal Chelation | Six coordination sites for metal ions; thiol group has alto(a) affinity for Cu, Zn, Hg, and Pb, forming estavel mercaptide complexes for mobilization and transport | Ballatori et al. (2009)[3] |
| NMDA Receptor Modulation | GSH modula the N-methyl-D-aspartate (NMDA) receptor, regulating calcium influx in cerebellar granule cells | Ballatori et al. (2009)[3] |
| Bcl-2 Binding | GSH binds the Bcl-2 BH3-domain groove no(a) mitochondria, contribuindo para anti-apoptotico(a) antioxidante function | Ballatori et al. (2009)[3] |
| γ-Peptide Bond Stability | Unusual γ-carboxyl linkage between glutamate and cysteine protege from intracellular peptidase hidrolise; apenas cleaved by ectoenzyme γ-glutamyl transpeptidase (GGT) on external cell surfaces | Ballatori et al. (2009)[3] |
Downstream Signaling Cascades
| Pathway | Mecanismo | Outcome |
|---|---|---|
| Keap1-Nrf2-ARE | Oxidative stress or electrophiles modify Keap1 cysteines, preventing Nrf2 degradacao; stabilized Nrf2 translocates to nucleus and binds Antioxidant Response Element (ARE); modulado(a) por ERK and p38 MAPK kinases | Transcription of GSH synthesis genes (GCLC, GCLM) and detoxification enzymes (GSTs)[3] |
| NF-κB Signaling | S-glutathionylation do(a) p50 subunit of NF-κB inibe its DNA binding; GSH depletion ativa NF-κB via ROS-mediated IκB degradacao | GSH suprime pro-inflamatorio(a) gene transcricao (TNF-α, IL-1β, IL-6); depletion drives inflamacao[3] |
| MAPK Pathway | Severe GSH depletion oxidizes MAPK phosphatases (MKPs), causing sustained JNK and p38 MAPK ativacao; GST-pi monomers bind JNK (inibicao), but dimerize under estresse oxidativo to release JNK | Cytochrome c release and caspase ativacao levando a apoptose[3] |
| Nitric Oxide (NO) Signaling | GSH buffers NO; depletion aumenta free NO causing protein nitration and DNA damage; ativa p53, que induz PGC-1α for antioxidante response | Modulation of NO-mediated signaling and protection against nitrosative stress[3] |
Cellular & Tissue-Level Effects
| System | Effect | Detail |
|---|---|---|
| Mitochondria | Critical for neutralizing H2O2 from electron transport chain | Transported via dicarboxylate and 2-oxoglutarate carriers; previne mPTP opening[3] |
| Skin (Antimelanogenic) | Inhibits tyrosinase by chelating copper at ativo(a) site | Shifts melanogenesis from eumelanin (dark) to pheomelanin (light); reduz melanin index, wrinkles, aumenta elasticity[19] |
| Nervous System | Astrocytes synthesize and release GSH for neuronal uptake | Protects dopaminergic neurons from oxidative damage; preserva mitochondrial Complex I activity[5] |
| Immune System | Essential for T-cell metabolic reprogramming and clonal expansion | GSH:GSSG ratio modula Th1/Th2 balance; depletion favors Th2 (chronic inflamacao)[14] |
| Cardiovascular | Restores endothelium-dependent vasorelaxation in aging | Increases H2S levels and mtNOS activity; inibe mPTP opening in aged heart tissue[3] |
| Hepatoprotective | Reduces ALT and oxidative damage markers in liver tissue | Significant benefit in NAFLD and NASH models[8] |
Comparison with Related Compounds
| Compound | Relationship to GSH | Key Difference |
|---|---|---|
| L-Cysteine | Rate-limiting precursor substrate for GSH synthesis | Neurotoxic at alto(a) extracellular concentrations; GSH e o(a) non-toxic storage form[3] |
| N-Acetylcysteine (NAC) | Deacetylated precursor used to replenish intracellular GSH | Better oral biodisponibilidade do que GSH; widely used clinically as GSH booster[7] |
| GSSG (Oxidized Glutathione) | Disulfide dimer formed quando GSH is oxidized | Accumulation is toxic; cells maintain GSH:GSSG ratio >100:1 via Glutathione Reductase + NADPH[3] |
| Liposomal Glutathione | GSH encapsulated in phospholipid vesicles | Enhanced oral absorcao bypassing GGT degradacao; elevates body stores and immune markers[14] |
| Glutathione Monoethyl Ester (GEE) | Synthetic analog designed for aprimorou cell penetration | Bypasses transport limitations; crosses blood-brain barrier mais effectively do que native GSH[3] |
Referencias
- Allen J, Bradley RD. Effects of oral glutathione supplementation on sistemico(a) estresse oxidativo biomarcadors in human volunteers. Journal of Alternative and Complementary Medicine, 17(9), 827-833, 2011.
- Arjinpathana N, Asawanonda P. Glutathione como um(a) oral whitening agent: a randomizado, duplo-cego, controlado por placebo study. Journal of Dermatological Treatment, 23(2), 97-102, 2012.
- Ballatori N, Krance SM, Notenboom S, Shi S, Tieu K, Hammond CL. Glutathione dysregulacao e o(a) etiology and progression of human diseases. Biological Chemistry, 390(3), 191-214, 2009.
- Cascinu S, Cordella L, Del Ferro E, et al. Neuroprotective effect of reduziu glutathione on cisplatin-based chemotherapy in advanced gastric cancer: a randomizado, duplo-cego, controlado por placebo trial. Journal of Clinical Oncology, 13(1), 26-32, 1995.
- Chinta SJ, Kumar MJ, Hsu M, et al. Inducible alterations of glutathione levels in adult dopaminergic midbrain neurons result in nigrostriatal degeneration. Journal of Neuroscience, 27(51), 13997-14006, 2007.
- Handog EB, Datuin MS, Singzon IA. An open-label, single-arm trial of a seguranca and efficacy of um(a) novo(a) preparation of glutathione como um(a) skin-lightening agent in Filipino women. International Journal of Dermatology, 55(2), 153-157, 2016.
- Holmay MJ, Terpstra M, Coles LD, et al. N-Acetylcysteine boosts brain and blood glutathione in Gaucher and Parkinson diseases. Clinical Neuropharmacology, 36(4), 103-106, 2013.
- Honda Y, Kessoku T, Sumida Y, et al. Efficacy of glutathione for o tratamento of nonalcoholic fatty doenca hepatico(a)a: an open-label, single-arm, multicenter, pilot study. BMC Gastroenterology, 17(1), 96, 2017.
- Kovacs-Nolan J, Rupa P, Matsui T, et al. In vitro and ex vivo uptake of glutathione (GSH) atraves do(a) intestinal epithelium and fate of oral GSH after in vivo supplementation. Journal of Agricultural and Food Chemistry, 62(39), 9499-9506, 2014.
- Lenzi A, Culasso F, Gandini L, Lombardo F, Dondero F. Placebo-controlled, duplo-cego, cross-over trial of glutathione therapy in male infertility. Human Reproduction, 8(10), 1657-62, 1993.
- Mischley LK, Leverenz JB, Lau RC, et al. A randomizado, duplo-cego phase I/IIa study of intranasal glutathione in Parkinson's disease. Movement Disorders, 30(12), 1696-1701, 2015.
- Richie JP, Nichenametla S, Neidig W, et al. Randomized controlled trial of oral glutathione supplementation on body stores of glutathione. European Journal of Nutrition, 54(2), 251-263, 2015.
- Sechi G, Deledda MG, Bua G, et al. Reduced intravenoso(a) glutathione in o tratamento of precoce Parkinson's disease. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 20(7), 1159-1170, 1996.
- Sinha R, Sinha I, Calcagnotto A, et al. Oral supplementation with liposomal glutathione elevates body stores of glutathione and markers of funcao imunologica. European Journal of Clinical Nutrition, 72(1), 105-111, 2018.
- Smyth JF, Bowman A, Perren T, et al. Glutathione reduz the toxicity and melhora qualidade de vida of women diagnosed with ovarian cancer treated with cisplatin: results of a duplo-cego, randomised trial. Annals of Oncology, 8(6), 569-73, 1997.
- Søndergård SD, Cintin I, Kuhlman AB, et al. The effects of 3 weeks of oral glutathione supplementation on whole body sensibilidade a insulina in obese males with and sem diabetes tipo 2: a randomizado trial. Applied Physiology, Nutrition, and Metabolism, 46(9), 1133-1142, 2021.
- Visca A, Bishop CT, Hilton S, Hudson VM. Oral reduziu L-glutathione melhora growth in pediatric cystic fibrose patients. Journal of Pediatric Gastroenterology and Nutrition, 60(6), 802-810, 2015.
- Watanabe F, Hashizume E, Chan GP, Kamimura A. Skin-whitening and skin-condition-improving effects of topico(a) oxidized glutathione: a duplo-cego and controlado por placebo ensaio clinico in healthy women. Clinical, Cosmetic and Investigational Dermatology, 7, 267-274, 2014.
- Weschawalit S, Thongthip S, Phutrakool P, Asawanonda P. Glutathione e seu(sua) antiaging and antimelanogenic effects. Clinical, Cosmetic and Investigational Dermatology, 10, 147-153, 2017.
- Witschi A, Reddy S, Stofer B, Lauterburg BH. The sistemico(a) availability of oral glutathione. European Journal of Clinical Pharmacology, 43(6), 667-669, 1992.
Perguntas de Pesquisa Relacionadas
APENAS PARA USO EM PESQUISA
Este conteudo e fornecido apenas para fins educacionais e informativos. Os produtos sao fornecidos apenas para estudos in vitro e nao sao medicamentos, drogas ou suplementos. Nao aprovado pela FDA para prevenir, tratar ou curar qualquer condicao.
